コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e predominant isolate was coagulase negative Staphylococci.
2 terotoxins excreted into foods by strains of staphylococci.
3 cal bacteria in addition to streptococci and staphylococci.
4 identified and readily transferred to other staphylococci.
5 gowns was performed with coagulase-negative staphylococci.
6 aB inhibitors to combat biofilm formation by staphylococci.
7 Ps) are highly conserved in streptococci and staphylococci.
8 hibit the growth and virulence of pathogenic staphylococci.
9 erial adhesins conserved in streptococci and staphylococci.
10 card for Enterococcus and the API system for staphylococci.
11 more efficient elimination of intracellular staphylococci.
12 esins that are conserved in streptococci and staphylococci.
13 Hla might prevent invasive skin infection by staphylococci.
14 ment of 25 cases of CIED endocarditis due to staphylococci.
15 Cmec) by horizontal gene transfer from other staphylococci.
16 Gap3 are conserved in many streptococci and staphylococci.
17 y of biofilm growth with special emphasis on staphylococci.
18 sA is central in cell division regulation in staphylococci.
19 nd complements the tagO mutant phenotypes of staphylococci.
20 patients infected with methicillin-sensitive staphylococci.
21 without inappropriate amplification of other staphylococci.
22 C test could predict the presence of mecA in staphylococci.
23 tively distinguish S. lugdunensis from other staphylococci.
24 f S. aureus when one of two cultures yielded staphylococci.
25 wo cultures is positive by Gram staining for staphylococci.
26 and antimicrobial resistance determinants of staphylococci.
27 s that have not been previously described in staphylococci.
28 nterpretations of nonsusceptible results for staphylococci.
29 Linezolid coverage was >98% against staphylococci.
30 LTA synthesis and the growth of ltaS mutant staphylococci.
31 vity against an array of multidrug-resistant staphylococci.
32 n and the risk of resistance to mupirocin in staphylococci.
33 itis, compared with other coagulase-negative staphylococci.
34 ating persisting intracellular reservoirs of staphylococci.
35 a-sheet peptide) against multidrug resistant staphylococci.
36 ing-protein 2a of methicillin resistant (MR) staphylococci.
37 lococci, 15 strains of methicillin-sensitive staphylococci, 10 strains of heterologous genera (all at
40 the sensor was tested with 36 strains of MR staphylococci, 15 strains of methicillin-sensitive staph
42 n oncology locations were coagulase-negative staphylococci (16.9%), Escherichia coli (11.8%), and Ent
43 ermidis (MSSE) (9), other coagulase-negative staphylococci (19), Streptococcus salivarius (5), Strept
44 g Escherichia coli (24%), coagulase-negative staphylococci (21%), and P. aeruginosa (16%), 394 (24%)
45 Common pathogens were coagulase-negative staphylococci (21%, 10/48) and methicillin-sensitive Sta
46 ausal microorganisms were coagulase-negative staphylococci (24%), followed by Staphylococcus aureus (
49 nerated data showed that oxacillin-resistant staphylococci (57.0% overall) had slightly higher dalbav
51 terquartile range, 59.8-77.6]); causation by staphylococci (62 [35.0% {95% CI, 28.0%-42.5%}] Staphylo
52 ne were active against oxacillin-susceptible staphylococci (82 to 99% susceptible), with lower suscep
55 a unique monophyletic group of odour-forming staphylococci about 60 million years ago, and has subseq
57 dards Institute were compared by testing 567 staphylococci against trimethoprim-sulfamethoxazole.
61 siella pneumoniae whereas Coagulase negative Staphylococci and Bacillus spp. are common causes of pos
62 This study generated susceptibility data for staphylococci and beta-hemolytic streptococci from 52 U.
63 t of wall teichoic acid (WTA) in bacilli and staphylococci and capsular polysaccharides (CPS) in stre
64 ctic acid bacteria were always present while staphylococci and coliform bacteria disappeared after 30
65 household transmission of S aureus and other staphylococci and describes contamination of household e
66 32-fold underestimation of activity against staphylococci and enterococci because of oritavancin's s
68 lightly declined, whereas coagulase-negative staphylococci and enterococci consistently increased ove
69 pparent increase in linezolid-nonsusceptible staphylococci and enterococci following a laboratory cha
70 recent emergence of linezolid-nonsusceptible staphylococci and enterococci is providing a challenge f
73 ethod for detecting linezolid-nonsusceptible staphylococci and enterococci, MicroScan results showed
76 ymes to their close relatives throughout the staphylococci and explore the substrate specificities of
77 ndispensable for opsonophagocytic killing of staphylococci and for protection against bloodstream inf
79 t mutation of residues that are conserved in staphylococci and major truncations abolished the inhibi
83 ibodies, which trigger phagocytic killing of staphylococci and protect mice against lethal bloodstrea
85 ibacterial compound active against resistant staphylococci and some clinically relevant Gram negative
87 cies; this may have clinical relevance since staphylococci and streptococci are the most common cause
88 ads among bacteria, with multidrug-resistant staphylococci and streptococci infections posing major t
89 comparative population genetics results for staphylococci and the first statistical evidence for a c
91 lieve the environmental hit in AD relates to staphylococci and their biofilms, which occlude sweat du
92 bility testing of other beta-lactams against staphylococci and to indicate that susceptibility to the
93 of TarM revealed an ancient origin in other staphylococci and vertical inheritance during S. aureus
94 s cultured were typically coagulase-negative staphylococci and were associated with increased levels
95 Staphylococcus aureus, or coagulase-negative staphylococci and who were being treated with intravenou
98 6% {95% CI, 24.9%-39.0%}] coagulase-negative staphylococci); and a high prevalence of health care-ass
99 ia, including enterococci, streptococci, and staphylococci, and antibodies against LTA have been show
100 ropionibacterium species, coagulase-negative staphylococci, and Corynebacterium species were the micr
102 om three gram-positive species (pneumococci, staphylococci, and group B streptococci) during the expo
103 e antibiotic with selective activity against staphylococci, and its biosynthesis involves the unprece
105 glycoproteins are conserved in streptococci, staphylococci, and lactobacilli, and are required for ba
106 porting recommendations for beta-lactams and staphylococci, and microbiologic data and clinical data
107 ded gram-positive cocci (45%), predominantly staphylococci, and nosocomial gram-negative bacilli (27%
109 cally relevant pathogens (e.g., enterococci, staphylococci, and streptococci) are Gram-positive (G+),
110 micin, possess activity against Enterococci, Staphylococci, and Streptococci, and other Gram-positive
111 rynebacterium, Acinetobacter, Brevundimonas, Staphylococci, Aquabacterium, Sphingomonas, Streptococcu
113 clinical observation that coagulase-negative staphylococci are a highly prominent infectious agent in
116 sions requires that these coagulase-positive staphylococci are accurately identified and specifically
118 y Sec (SecA2/Y2) systems of streptococci and staphylococci are dedicated to the transport of large se
119 Further, EsaC production is repressed when staphylococci are grown in broth and increased when stap
120 ycoproteins identified from streptococci and staphylococci are important for bacterial adhesion and b
121 oteins (SRRPs) conserved in streptococci and staphylococci are important for bacterial colonization a
125 gram-positive (G(+)) bacteria, most commonly staphylococci, are thought to be the main pathogens.
126 p with cellular GTPases is not unique to the staphylococci, as homologs from Bacillus subtilis and En
128 ploits the specificity and physiology of the Staphylococci bacteriophage K to identify Staphylococcus
129 In post-meconium samples, the abundance of staphylococci became negatively associated with NEC deve
131 ction of inducible clindamycin resistance in staphylococci, but only a disk approximation test for th
132 e not yet known, opsonophagocytic killing of staphylococci by phagocytic cells offers opportunities t
133 Taken together, MyD88-dependent sensing of staphylococci by resident dermal Mvarphis is key for a r
134 t, we characterize a genetic locus unique to staphylococci called rsr that has a role in repressing t
135 ve poor final acuity than coagulase-negative staphylococci cases (adjusted OR, 11.28; 95% CI, 3.63-35
137 Staphylococcus aureus and coagulase-negative staphylococci clinical isolates cultured at our institut
138 sistance of S. aureus and coagulase negative staphylococci clinical isolates to tetracycline or rifam
140 he dominant isolates were Coagulase negative Staphylococci (CNS) 9(29.0%), Staphylococcus aureus (S.
144 s, Staphylococcus aureus, coagulase-negative staphylococci (CNS), Peptostreptococcus spp., Bacteroide
146 of this enzyme alone to non-odour producing staphylococci confers odour production, demonstrating th
148 ted pathogen, followed by Coagulase negative staphylococci (CoNS) (33.5%) and Klebsiella species (4.7
149 organisms identified were Coagulase-negative Staphylococci (CoNS) [65.9% (91/138)] and Staphylococcus
150 ferentiate S. aureus from coagulase-negative staphylococci (CoNS) and other Gram-positive cocci (GPC)
152 transfer originating from coagulase-negative staphylococci (CoNS) and through clonal transmission.
154 uggest that skin-dwelling coagulase-negative staphylococci (CoNS) can prime the skin immune system to
157 e, virulent member of the coagulase-negative staphylococci (CoNS) that is responsible for severe, rap
158 s-level identification of coagulase-negative staphylococci (CoNS) using matrix-assisted laser desorpt
159 Staphylococcus aureus and coagulase-negative staphylococci (CoNS) were 99.5% (217/218) and 98.8% (487
161 ant S. aureus (MRSA), and coagulase-negative staphylococci (CoNS), including methicillin-resistant Co
162 of Staphylococcus aureus, coagulase-negative staphylococci (CoNS), Streptococcus pneumoniae, Haemophi
165 caused by enterococci and coagulase-negative staphylococci (CoNS; adjusted SHR, 0.91; 95% CI, .50-1.6
166 (SIG) is a collection of coagulase-positive staphylococci consisting of four distinct species, namel
167 reviews beta-lactam resistance mechanisms in staphylococci, current antimicrobial susceptibility test
168 ed tissues using a specific antibody against staphylococci demonstrated the presence of thick clumps
169 reaction for species-level identification of staphylococci, detection of genes encoding Panton-Valent
172 ss lesions into purulent exudate, with which staphylococci disseminate to produce new infectious lesi
176 defence against serious infections caused by staphylococci, enterococci and other Gram-positive bacte
179 portions were highest for coagulase-negative staphylococci followed by gram-negative rods and Staphyl
180 cycle activity can be induced by preventing staphylococci from exogenously acquiring a TCA cycle-der
184 such as vancomycin-resistant Enterococci and Staphylococci has become a major global health hazard.
185 CR), which confers methicillin resistance in staphylococci, has the added potential to reduce antibio
186 d Methanobrevibacter smithii associated with staphylococci in 14 patients, fermentative Enterobacteri
187 s in 5.8% (26/443), other coagulase-negative staphylococci in 6.0% (27/448), Propionibacterium acnes
188 le modulins, surfactant peptides secreted by staphylococci in a quorum-sensing controlled fashion, st
190 e associated with reduced survival of mutant staphylococci in blood and diminished virulence in mice.
193 sor described has the potential to detect MR staphylococci in clinical samples with a high degree of
195 alpha-helical peptides that are secreted by staphylococci in high amounts in a quorum-sensing-contro
200 rated activity against methicillin-resistant staphylococci including investigational cephalosporins,
201 ctive in vitro bactericidal activity against staphylococci, including methicillin- and multi-drug-res
202 showed strong antibacterial activity against staphylococci, including MRSA strain, but did not affect
205 ne responsible for methicillin resistance in staphylococci, inserts into the chromosome at a specific
206 y to recruit PML within hours in response to staphylococci, irrespective of bacterial viability.
207 tect mecA-mediated beta-lactam resistance in staphylococci is becoming more complex as species-specif
210 tention is being paid to multidrug resistant staphylococci isolated from healthcare and non-healthcar
213 though the agr system is conserved among the staphylococci, it has undergone significant evolutionary
214 occi were less bactericidal and cocolonizing staphylococci less susceptible to this effect; however,
215 ersistence in a range of microbes, including staphylococci, listeriae, clostridia, and enterococci.
216 icillin and other beta-lactam antibiotics in staphylococci, mecA, is carried on a genomic island, SCC
217 he accessory Sec systems of streptococci and staphylococci mediate the transport of a family of large
218 rug has demonstrated potent activity against staphylococci (minimum inhibitory concentration [MIC] fo
219 confirm whether colonization with commensal staphylococci modulates skin immunity and attenuates dev
220 on, which in turn renders the lukAB-negative staphylococci more susceptible to killing by neutrophils
221 biology of the disease has also changed, and staphylococci, most often associated with health-care co
223 challenge panel of enterococci (n = 50) and staphylococci (n = 50), including 17 and 15 isolates tha
225 taphylococcus aureus (SAU) and by non-aureus staphylococci (NAS) is a major issue in the water buffal
227 nd other superantigens by coagulase-negative staphylococci, no associated pathogenicity islands have
229 following sensitivities (coagulase-negative staphylococci not included): Gram-positive bacteria, 58%
231 ne sensitivity testing in coagulase-negative staphylococci often lead to the use of potentially less-
232 e samples (730) contained coagulase-negative staphylococci or nonstaphylococci as assessed by the Qui
233 to cause serious diseases from the vaginal (staphylococci) or oral mucosa (streptococci) of the body
235 .5%), and 13 (14.1%) were coagulase-negative staphylococci, other gram-positive, and gram-negative ba
237 tly higher proportion of multidrug resistant staphylococci (P = 0.0002) in East London (56.7%) compar
238 niae and Escherichia coli in Conjunctivitis; Staphylococci, P. aeruginosa and E. coli in dacryocystit
241 . coli in dacryocystitis; Coagulase negative Staphylococci, Pseudomonas aeruginosa and Staphylococcus
242 ococci are grown in broth and increased when staphylococci replicate in serum or infected hosts.
243 l as collagen deposits and immune cells with staphylococci replicating at the center of these lesions
249 portant human bacterial pathogens, including staphylococci, streptococci, and borrelia, likewise prod
250 er dividing the isolates into two subgroups, staphylococci, streptococci, and enterococci (n = 217) a
251 tection of 12 different organisms, including staphylococci, streptococci, and enterococci, as well as
253 e identification of 305 clinical isolates of staphylococci, streptococci, and related genera by compa
254 eral, regional differences in activity among staphylococci, streptococci, Haemophilus spp., and Morax
255 S rRNA gene PCR/pyrosequencing as containing staphylococci, streptococci, or enteric Gram-negative ro
256 w, Staphylococcus aureus, Coagulase negative Staphylococci, Streptococcus pneumoniae and Pseudomonas
257 of the respective clinical diagnose include Staphylococci, Streptococcus pyogenes and Pseudomonas ae
258 s and Pseudomonas aeruginosa in blepharitis; Staphylococci, Streptococus pneumoniae, Pseudomonas aeru
259 in 2009, the CLSI altered the guidelines for staphylococci such that disk diffusion was no longer an
260 soluble hTSP-1 to proteolytically pretreated staphylococci suggested a proteinaceous nature of potent
261 engitide inhibited adherence and invasion by staphylococci, suggesting that Vn acts as a bridge betwe
263 a bacterial enzyme, limited to odour-forming staphylococci that are able to cleave odourless precurso
264 14- to 17-kb mobile pathogenicity islands in staphylococci that carry genes for superantigen toxins a
265 esins found in a variety of streptococci and staphylococci that have been implicated in bacterial pat
269 ic gram-positive cocci (GPC), and especially staphylococci, the most common causative organisms.
271 Although early colonization is dominated by Staphylococci, their significant decline contributes to
273 dispensable for the early immune response to staphylococci, they contributed to Mvarphi renewal after
274 rial adhesins found in many streptococci and staphylococci; they play important roles in bacterial bi
276 TarP diminishes WTA immunogenicity, allowing staphylococci to evade host adaptive immune responses, a
278 , leading to increased binding of CS-treated staphylococci to immobilized fibronectin and increased a
279 ted binding efficiency for late growth phase staphylococci to immobilized platelets, compared with th
280 lammatory cell death, which was required for staphylococci to penetrate across a keratinocyte barrier
281 tic resistance genes and immunizes avirulent staphylococci to prevent the spread of plasmid-borne res
282 ases corisin, a peptide conserved in diverse staphylococci, to induce apoptosis of lung epithelial ce
283 vidual transcript responses to Hla-secreting staphylococci was notable for upregulation of host cytok
288 of 73% contamination when coagulase-negative staphylococci were identified, 67.6% prevalence of risk
298 Phi function is supported by the response to staphylococci, where TLR13 and UNC-93B limit the cytokin
299 cross-walls and in the relative abundance of staphylococci with cross-walls, suggesting that spd muta
300 fected samples contained multidrug-resistant staphylococci, with S aureus (42.0%) and Staphylococcus